• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Latest News about Alzheimer’s

    Recent news which mentions Alzheimer’s

    EXCLUSIVE: New Alzheimer's Treatment? Promising Cannabinoid Compound Shows Hope, InMed CEO Says
    Tags Health Care Benzinga Events
    From Benzinga
    EXCLUSIVE: Alzamend Seeks FDA Approval For Study For Upgraded Version Of Most Commonly Used Treatment For Bipolar Disorder
    Tickers ALZN
    Tags General Briefs Market News
    From Benzinga
    Eli Lilly's Alzheimer's Drug Candidate Slows Progression By 60% In Mildly Impaired Patients
    Tickers LLY
    Tags News LLY Biotech
    From Benzinga
    Bernie Sanders Takes on High Costs of Alzheimer's Treatment Leqembi, Calls Price Tag 'Unconscionable'
    Tickers BIIB ESALF ESALY
    Tags News BIIB Alzheimer’s
    From Benzinga
    Stress-Related Mood Disorders And Alzheimer's: Can This Patented Ketamine Drug Help?
    Tickers SILO
    Tags Benzinga Markets Psychedelic/Assisted Therapies
    From Benzinga
    Will US Medicare Fully Cover Alzheimer's Drugs? Eli Lilly Thinks Yes!
    Tickers BIIB ESALF ESALY LLY
    Tags Government Biotech ESALY
    From Benzinga
    National Institute on Aging Aims Building $300M Alzheimer's Research Database
    Tickers BIIB ESALF ESALY
    Tags Briefs General ESALF
    From Benzinga
    EXCLUSIVE: Alzamend Neuro Starts Phase 1/2A Trial For Its Alzheimer's Immunotherapy Vaccine
    Tickers ALZN
    Tags Biotech Exclusives Benzinga
    From Benzinga
    Alzheimer's Association Launches Grassroots Level Lobbying For Medicare Coverage Of Alzheimer's Treatments
    Tickers BIIB ESALF ESALY LLY
    Tags ESALY Biotech Regulations
    From Benzinga
    Biogen's 2nd Alzheimer's Antibody, BeiGene's Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors
    Tickers BGNE BIIB CDTX CHRS
    Tags News BIIB REGN
    From Benzinga
    Roche's Another Alzheimer's Hopeful Flops In Phase 3 Program, Second Trial Setback Within Months
    Tickers MOR RHHBF RHHBY RHHVF
    Tags News Small Cap Alzheimer’s
    From Benzinga
    Why Shares Of Eli Lilly And Biogen Are Rallying Today
    Tickers BIIB ESALY LLY RHHBY
    Tags why it's moving Biotech ESALY
    From Benzinga
    These Stocks Are On The Radar After Biogen-Eisai's Surprising Alzheimer's Trial Win
    Tickers ABOS ACIU ALZN ANVS
    Tags NVO Trading Ideas LGVN
    From Benzinga
    Flu Shots Can Cut Down Risk Of Alzheimer's, Exploratory Study Finds
    Tickers IBB
    Tags McGovern Medical School Health Care General
    From Benzinga
    Biogen's Alzheimer's Drug Aduhelm Medicare Coverage Restricted To Just Clinical Trials, CMS Finalizes
    Tickers BIIB
    Tags Benzinga Health Care Government
    From Benzinga
    EXCLUSIVE: Longeveron's Lomecel-B Data In Alzheimer's Disease Published In Medical Journal
    Tickers LGVN
    Tags Phase 1 Trial News General
    From Benzinga
    How CBD Helps Seniors With Alzheimer's And Dementia, Start With The Basics!
    Tickers CBD
    Tags General Cannabis Alzheimer’s
    From Benzinga
    Acadia Resubmits Pimavanserin US Application For Expanded Use In Alzheimer's Psychosis
    Tickers ACAD
    Tags Market News FDA Benzinga
    From Benzinga
    Citi Upgrades This Big Pharma Stock On Positive Alzheimer's Expectations
    Tickers LLY
    Tags Briefs General Price Target
    From Benzinga
    Cassava Sciences Receives FDA's Special Protocol Assessment For Alzheimer's Trials
    Tickers SAVA
    Tags Biotech SAVA FDA
    From Benzinga
    White House Dismisses Janet Woodcock As Permanent FDA Commissioner Candidate: Bloomberg
    Tickers BIIB ESALF ESALY
    Tags BIIB News Alzheimer’s
    From Benzinga
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.